The effect of fluence rate on the acute response of vessel diameter and red blood cell velocity during topical 5-aminolevulinic acid photodynamic therapy.
暂无分享,去创建一个
H. S. de Bruijn | D. Robinson | F. van Leeuwen-van Zaane | A. van der Ploeg-van den Heuvel | H S de Bruijn | A van der Ploeg-van den Heuvel | D J Robinson | F van Leeuwen-van Zaane | H J M C Sterenborg | H. Sterenborg
[1] H. S. de Bruijn,et al. Fractionated illumination after topical application of 5-aminolevulinic acid on normal skin of hairless mice: the influence of the dark interval. , 2006, Journal of photochemistry and photobiology. B, Biology.
[2] Stanley B. Brown,et al. Protoporphyrin IX Fluorescence Photobleaching during ALA‐Mediated Photodynamic Therapy of UVB‐Induced Tumors in Hairless Mouse Skin , 1999, Photochemistry and photobiology.
[3] B. Henderson,et al. PHOTOSENSITIZATION OF MURINE TUMOR, VASCULATURE and SKIN BY 5‐AMINOLEVULINIC ACID‐INDUCED PORPHYRIN , 1995, Photochemistry and photobiology.
[4] P B Cerrito,et al. The role of microvascular damage in photodynamic therapy: the effect of treatment on vessel constriction, permeability, and leukocyte adhesion. , 1992, Cancer Research.
[5] R S Reneman,et al. Velocity Profiles of Blood Platelets and Red Blood Cells Flowing in Arterioles of the Rabbit Mesentery , 1986, Circulation research.
[6] W. Star,et al. Photodynamic Effectiveness and Vasoconstriction in Hairless Mouse Skin after Topical 5‐Aminolevulinic Acid and Single‐ or Two‐fold Illumination , 1999, Photochemistry and photobiology.
[7] D. Kessel,et al. Tumor blood-flow changes following protoporphyrin IX-based photodynamic therapy in mice and humans. , 1999, Journal of photochemistry and photobiology. B, Biology.
[8] M S Patterson,et al. Singlet oxygen luminescence as an in vivo photodynamic therapy dose metric: validation in normal mouse skin with topical amino-levulinic acid , 2005, British Journal of Cancer.
[9] Henricus J C M Sterenborg,et al. Light fractionated ALA-PDT enhances therapeutic efficacy in vitro; the influence of PpIX concentration and illumination parameters , 2013, Photochemical and Photobiological Sciences.
[10] H. S. de Bruijn,et al. Topical hexylaminolevulinate and aminolevulinic acid photodynamic therapy: complete arteriole vasoconstriction occurs frequently and depends on protoporphyrin IX concentration in vessel wall. , 2013, Journal of Photochemistry and Photobiology. B: Biology.
[11] M E Dickinson,et al. Measuring hemodynamic changes during mammalian development. , 2004, American journal of physiology. Heart and circulatory physiology.
[12] W. Star,et al. Effect of photodynamic therapy on the endothelium-dependent relaxation of isolated rat aortas. , 1993, Cancer research.
[13] B. Zweifach,et al. Application of the "two-slit" photometric technique to the measurement of microvascular volumetric flow rates. , 1978, Microvascular research.
[14] N. Otsu. A threshold selection method from gray level histograms , 1979 .
[15] Ulas Sunar,et al. Monitoring blood flow responses during topical ALA-PDT , 2010, Biomedical optics express.
[16] Ken Kang-Hsin Wang,et al. Simulations of measured photobleaching kinetics in human basal cell carcinomas suggest blood flow reductions during ALA‐PDT , 2009, Lasers in surgery and medicine.
[17] W. Star,et al. In vivo fluorescence kinetics and photodynamic therapy using 5-aminolaevulinic acid-induced porphyrin: increased damage after multiple irradiations. , 1994, British Journal of Cancer.
[18] V. Schacht,et al. Photodynamic therapy with 5-aminolevulinic acid induces distinct microcirculatory effects following systemic or topical application , 2006, Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology.
[19] Ann-Marie Wennberg,et al. Guidelines on the use of photodynamic therapy for nonmelanoma skin cancer: an international consensus. International Society for Photodynamic Therapy in Dermatology, 2005. , 2007, Journal of the American Academy of Dermatology.
[20] Q. Peng,et al. 5‐Aminolevulinic Acid‐Based Photodynamic Therapy: Principles and Experimental Research , 1997, Photochemistry and photobiology.
[21] C. Morton,et al. Guidelines for topical photodynamic therapy: update , 2008, The British journal of dermatology.
[22] N. J. Brown,et al. The effect of aminolaevulinic acid-induced, protoporphyrin IX-mediated photodynamic therapy on the cremaster muscle microcirculation in vivo. , 1995, British Journal of Cancer.
[23] J. Borredon,et al. Dynamic In Vivo Measurement of Erythrocyte Velocity and Flow in Capillaries and of Microvessel Diameter in the Rat Brain by Confocal Laser Microscopy , 1999, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[24] R. Jain,et al. Role of nitric oxide in tumor microcirculation. Blood flow, vascular permeability, and leukocyte-endothelial interactions. , 1997, The American journal of pathology.
[25] R. Jain,et al. Angiogenesis, microvascular architecture, microhemodynamics, and interstitial fluid pressure during early growth of human adenocarcinoma LS174T in SCID mice. , 1992, Cancer research.
[26] C. Foote. DEFINITION OF TYPE I and TYPE II PHOTOSENSITIZED OXIDATION , 1991, Photochemistry and photobiology.
[27] D. Robinson,et al. Topical Photodynamic Therapy Using Different Porphyrin Precursors Leads to Differences in Vascular Photosensitization and Vascular Damage in Normal Mouse Skin , 2014, Photochemistry and photobiology.
[28] Stanley B. Brown,et al. Fluorescence Photobleaching of ALA‐induced Protoporphyrin IX during Photodynamic Therapy of Normal Hairless Mouse Skin: The Effect of Light Dose and Irradiance and the Resulting Biological Effect , 1998, Photochemistry and photobiology.